share_log

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%), etc.

SEC ·  May 2 05:12
Summary by Futu AI
EyePoint Pharmaceuticals, Inc. has been the subject of a Schedule 13G/A filing with the Securities and Exchange Commission, indicating a change in ownership by certain significant investors. The filing, dated April 30, 2024, was submitted by Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, who collectively reported shared voting and dispositive power over 5,156,299 shares of EyePoint Pharmaceuticals' common stock. This stake represents 9.90% of the company's class of securities. The filing amends and replaces the previous Schedule 13G filed on the same date in 2023. The shares are reported to be held in the ordinary course of business, with no intention of changing or influencing the control of the issuer. The principal business office for the reporting persons is located at 200 Clarendon Street, 52nd Floor, Boston, Massachusetts.
EyePoint Pharmaceuticals, Inc. has been the subject of a Schedule 13G/A filing with the Securities and Exchange Commission, indicating a change in ownership by certain significant investors. The filing, dated April 30, 2024, was submitted by Adage Capital Management, L.P., along with individuals Robert Atchinson and Phillip Gross, who collectively reported shared voting and dispositive power over 5,156,299 shares of EyePoint Pharmaceuticals' common stock. This stake represents 9.90% of the company's class of securities. The filing amends and replaces the previous Schedule 13G filed on the same date in 2023. The shares are reported to be held in the ordinary course of business, with no intention of changing or influencing the control of the issuer. The principal business office for the reporting persons is located at 200 Clarendon Street, 52nd Floor, Boston, Massachusetts.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.